Atlas Trials

Klus Pharma Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Klus Pharma Inc.

RecordFirmDate
A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003) (NCT05816252)Klus Pharma Inc.2023-04-19
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors (NCT05642780)Klus Pharma Inc.2023-01-17
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) (NCT04152499)Klus Pharma Inc.2020-02-28

Track Klus Pharma Inc. automatically

Every clearance here is in the API, with alerts when new ones post.